Would you sell your DNA as a non-fungible token?- Future Health – Issue 39: CogX – Health & Epidemiology Briefing

Future of Health

Orchid, a company that helps couples have healthy babies by offering a new type of genetic test, has announced a $4.5 million seed funding round as it creates the first test on the market to examine the whole genome of both partners and evaluate the genetic risk of their child having common chronic diseases.

They claim that most genetic tests typically only analyze about 2% of your DNA with a genotyping chip, but they analyze the entire genome.

At the same time, famed geneticist and Harvard University professor George Church has launched a genetic sequencing service called Nebula Genomics — and the company is putting Church’s own DNA for sale as a non-fungible token (NFT).

Perhaps in the future, celebrities and influencers will offer their DNA for sale as NFTs too?




P.S. Explore ‘NFTs and the Future of Digital Art’ at CogX Festival 2021. Buy your pass now!

P.P.S. Claim your free virtual pass to CogX Festival 2021! Apply our code: COGX21NEWSHEALTHSVP and use: COGX21NEWSHEALTH for 50% off any festival pass. Sign up now.

P.P.P.S. Catch me talking about this year’s festival on Hopin’s podcast, ‘Back of House Live’ today at 6PM GMT.


Orchid recently announced a $4.5 million seed funding round as it created the first test on the market to examine the whole genome of both partners and evaluate the genetic risk of their child having common chronic diseases. And George Church’s DNA is up for sale as a non-fungible token (NFT).

Read more (AME Info)


A recent report outlines the opportunities for using Virtual Reality and Augmented Reality in UK Healthcare. It was carried out in partnership with the NHS. It gives plenty of insight into what the future of a technology-enabled NHS healthcare system could look like and sketches out ways in which immersive technologies could help drive efficiency savings.

Read more (Forbes)




Want to increase your brand awareness, generate leads, raise capital and grow your networks? Apply for your free CogX Festival 2021 Virtual Expo Booth (normally £995) on 14th-16th June now!

Claim yours today



blind man has regained some vision in one eye thanks to an innovative treatment using genetic engineering and light-activated therapy.The 58-year-old was diagnosed almost 40 years ago with a neurodegenerative eye disease that affects the retina at the back of the eye and stops it from working. But genes from algae helped him recover.

Read more (Stat News)


Researchers in Australia have flipped traditional 3D printing to create some of the most intricate biomedical structures yet, advancing the development of new technologies for regrowing bones and tissue. Until now this was considered impossible with standard 3D printers.

Read more (Medical Xpress)



As subscribers to this newsletter, we’re offering you a free CogX Festival 2021 Standard Virtual Pass. Gain unmissable insights from the world’s-best CEOs, Activists & Policymakers across 18 stages whilst networking with over 100,000 attendees – All for free. Join us on 14-16th June.

Claim yours today


Why is it that some adults are short, while others are as tall as professional basketball players? Researchers looking for the answer have found it largely relates to genes. Indeed, studies looking for metrics and variables that can be used to predict a person’s height have found that genetics is a powerful indicator.

Read more (Live Science)



Tell us by sharing it with your network.

Recommend0 recommendationsPublished in Future Health

Related Articles